IL6 and cholangiocarcinoma: Co-cultivation of the two CCA cell lines HuCCT-1 and TFK-1 with CAF increased tumor cell migration and secretion of the pro-inflammatory cytokines MCP-1, CXCL-1, IL-6 and IL-8, which could be clearly diminished by Sorafenib treatment.